303 related articles for article (PubMed ID: 35889301)
1. Cyclic Peptides for the Treatment of Cancers: A Review.
Ramadhani D; Maharani R; Gazzali AM; Muchtaridi M
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889301
[TBL] [Abstract][Full Text] [Related]
2. Targeting signal pathways triggered by cyclic peptides in cancer: Current trends and future challenges.
Yang Y; Mao H; Chen L; Li L
Arch Biochem Biophys; 2021 Apr; 701():108776. PubMed ID: 33515532
[TBL] [Abstract][Full Text] [Related]
3. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.
Tornesello AL; Buonaguro L; Tornesello ML; Buonaguro FM
Molecules; 2017 Aug; 22(8):. PubMed ID: 28767081
[TBL] [Abstract][Full Text] [Related]
4. Natural Cyclic Peptides as an Attractive Modality for Therapeutics: A Mini Review.
Abdalla MA; McGaw LJ
Molecules; 2018 Aug; 23(8):. PubMed ID: 30127265
[TBL] [Abstract][Full Text] [Related]
5. Development and Challenges of Cyclic Peptides for Immunomodulation.
Jiang X; Gao L; Li Z; Shen Y; Lin ZH
Curr Protein Pept Sci; 2024; 25(5):353-375. PubMed ID: 37990433
[TBL] [Abstract][Full Text] [Related]
6. Marine Peptides as Anticancer Agents: A Remedy to Mankind by Nature.
Negi B; Kumar D; Rawat DS
Curr Protein Pept Sci; 2017; 18(9):885-904. PubMed ID: 27455970
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a Direct Ras Inhibitor by Screening a Combinatorial Library of Cell-Permeable Bicyclic Peptides.
Trinh TB; Upadhyaya P; Qian Z; Pei D
ACS Comb Sci; 2016 Jan; 18(1):75-85. PubMed ID: 26645887
[TBL] [Abstract][Full Text] [Related]
8. Multicyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents.
Loktev A; Haberkorn U; Mier W
Curr Med Chem; 2017; 24(20):2141-2155. PubMed ID: 28302013
[TBL] [Abstract][Full Text] [Related]
9. Improved anticancer potency by head-to-tail cyclization of short cationic anticancer peptides containing a lipophilic β(2,2) -amino acid.
Tørfoss V; Isaksson J; Ausbacher D; Brandsdal BO; Flaten GE; Anderssen T; Cavalcanti-Jacobsen Cde A; Havelkova M; Nguyen LT; Vogel HJ; Strøm MB
J Pept Sci; 2012 Oct; 18(10):609-19. PubMed ID: 22933412
[TBL] [Abstract][Full Text] [Related]
10. Structural diversity of marine cyclic peptides and their molecular mechanisms for anticancer, antibacterial, antifungal, and other clinical applications.
Lee Y; Phat C; Hong SC
Peptides; 2017 Sep; 95():94-105. PubMed ID: 28610952
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells.
Hou L; Zhao X; Wang P; Ning Q; Meng M; Liu C
PLoS One; 2013; 8(1):e53491. PubMed ID: 23326440
[TBL] [Abstract][Full Text] [Related]
12. [Lanreotide++: a new therapeutic option in acromegaly].
Díez JJ
Med Clin (Barc); 1996 Sep; 107(7):257-69. PubMed ID: 8975096
[No Abstract] [Full Text] [Related]
13. Marine Depsipeptides as Promising Pharmacotherapeutic Agents.
Rangel M; de Santana CJ; Pinheiro A; Dos Anjos L; Barth T; Pires OR; Fontes W; Castro MS
Curr Protein Pept Sci; 2017; 18(1):72-91. PubMed ID: 27226199
[TBL] [Abstract][Full Text] [Related]
14. Natural Cyclopeptides as Anticancer Agents in the Last 20 Years.
Zhang JN; Xia YX; Zhang HJ
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921480
[TBL] [Abstract][Full Text] [Related]
15. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.
Pacifico S; Santucci M; Luciani R; Saxena P; Linciano P; Ponterini G; Lauriola A; D'Arca D; Marverti G; Guerrini R; Costi MP
Molecules; 2019 Sep; 24(19):. PubMed ID: 31561530
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Small Peptides of Marine Origin in Cancer Therapy.
Zhang QT; Liu ZD; Wang Z; Wang T; Wang N; Wang N; Zhang B; Zhao YF
Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33669851
[TBL] [Abstract][Full Text] [Related]
17. Anti-Cancer Peptides: Status and Future Prospects.
Ghaly G; Tallima H; Dabbish E; Badr ElDin N; Abd El-Rahman MK; Ibrahim MAA; Shoeib T
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770815
[TBL] [Abstract][Full Text] [Related]
18. A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity.
Matsuo AL; Tanaka AS; Juliano MA; Rodrigues EG; Travassos LR
J Mol Med (Berl); 2010 Dec; 88(12):1255-64. PubMed ID: 20802991
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Evidence on the Anticancer Properties of Food Peptides.
Rajendran SR; Ejike CE; Gong M; Hannah W; Udenigwe CC
Protein Pept Lett; 2017; 24(2):126-136. PubMed ID: 27538700
[TBL] [Abstract][Full Text] [Related]
20. A gold mine for drug discovery: Strategies to develop cyclic peptides into therapies.
Jing X; Jin K
Med Res Rev; 2020 Mar; 40(2):753-810. PubMed ID: 31599007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
